Keeler & Nadler Financial Planning & Wealth Management’s Gilead Sciences GILD Stock Holding History

Keeler & Nadler Financial Planning & Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$263K	Hold	2,080	–	–	0.07%	76
2026 Q1	$290K	Hold	2,080	–	–	0.1%	68
2025 Q4	$255K	Hold	2,080	–	–	0.09%	71
2025 Q3	$231K	Buy	2,080 +1	+0%	+$114	0.08%	73
2025 Q2	$230K	Buy	2,079 +4	+0.2%	+$426	0.09%	69
2025 Q1	$232K	Buy	+2,075	New	+$214K	0.1%	66

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Keeler & Nadler Financial Planning & Wealth Management's GILD Position: Q2 2026 in Review

Keeler & Nadler Financial Planning & Wealth Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,080 shares worth $263K. The position accounts for 0.07% of the portfolio, ranked #76.

Keeler & Nadler Financial Planning & Wealth Management first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $290K in Q1 2026. 1,511 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Keeler & Nadler Financial Planning & Wealth Management held 2,080 shares of Gilead Sciences worth $263K as of Q2 2026.
Keeler & Nadler Financial Planning & Wealth Management left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.07% of Keeler & Nadler Financial Planning & Wealth Management's portfolio in Q2 2026, its #76 holding.
Keeler & Nadler Financial Planning & Wealth Management first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
Keeler & Nadler Financial Planning & Wealth Management's Gilead Sciences position peaked at $290K in Q1 2026.
1,511 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Keeler & Nadler Financial Planning & Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.